David P. Nicolau
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance 156
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria 427
- Pharmacology top 0.01%
- Antibiotics Pharmacokinetics and Efficacy 553
- Clinical Biochemistry top 0.05%
- Bacterial Identification and Susceptibility Testing 112
- Epidemiology top 0.1%
- Pneumonia and Respiratory Infections 245
- Urinary Tract Infections Management 29
-
- Antimicrobial Resistance in Staphylococcus 115
-
- Nosocomial Infections in ICU 34
- Co-authors
- Joseph L. KutiCharles H. NightingaleJared L. CrandonRichard QuintilianiChristina SutherlandCatharine C. BulikC H NightingaleKamilia Abdelraouf
- Journals
- SHILAP Revista de lepidopterología (3 papers)Clinical Microbiology Reviews (1 paper)Clinical Infectious Diseases (11 papers)
- Partner nations
- United StatesSaudi ArabiaJapan
In The Last Decade
David P. Nicolau
728 papers receiving 18.1k citations
Peers
Comparison fields: 5 of 166
- Applied Microbiology and Biotechnology 4.3k
- Molecular Medicine 9.9k
- Pharmacology 11.6k
- Clinical Biochemistry 2.5k
- Epidemiology 7.4k
Countries citing papers authored by David P. Nicolau
This map shows the geographic impact of David P. Nicolau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Nicolau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Nicolau more than expected).
Fields of papers citing papers by David P. Nicolau
This network shows the impact of papers produced by David P. Nicolau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Nicolau. The network helps show where David P. Nicolau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David P. Nicolau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 124 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 21 | |
| 16 | 2020 | 21 | |
| 17 | 2019 | 14 | |
| 18 | 2018 | 54 | |
| 19 | Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles | 2008 | 2 |
| 20 | 1999 | 6 |
About David P. Nicolau
David P. Nicolau is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 739 papers that have together received 18.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (553 papers), Antibiotic Resistance in Bacteria (427 papers), Pneumonia and Respiratory Infections (245 papers), Antibiotic Use and Resistance (156 papers), Antimicrobial Resistance in Staphylococcus (115 papers), Bacterial Identification and Susceptibility Testing (112 papers), Nosocomial Infections in ICU (34 papers) and Urinary Tract Infections Management (29 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (4.3k citations), Molecular Medicine (9.9k citations) and Pharmacology (11.6k citations). David P. Nicolau has collaborated with scholars based in United States, Saudi Arabia and Japan. Frequent co-authors include Joseph L. Kuti, Charles H. Nightingale, Jared L. Crandon, Richard Quintiliani, Christina Sutherland, Catharine C. Bulik, C H Nightingale, Kamilia Abdelraouf, Pamela R. Tessier and Mary Anné Banevicius. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.